Latest 10-K annual reports

Zevia PBC reported a significant reduction in net loss for 2025, driven by increased net sales and benefits from its multi-year Productivity Initiative, despite ongoing macroeconomic challenges and tariff impacts.

Magnite reports significant net income and Adjusted EBITDA growth in 2025, driven by strong performance in Connected Television (CTV) and strategic acquisitions, alongside a new share repurchase program.

WisdomTree, Inc. announced robust financial results for 2025, with assets under management increasing by 31.6% to $144.5 billion, driven by market appreciation and net inflows, alongside strategic expansion into private assets and digital offerings.

Columbia Sportswear reports a 1% net sales increase in 2025, driven by international growth and strategic brand investments, despite U.S. market pressures and tariff impacts.

Diamondback Energy's 2025 saw significant acquisitions, a $3.7 billion asset impairment, and a strategic focus on debt reduction and capital returns amidst fluctuating commodity prices.

Nucor Corporation reports a dip in 2025 net earnings to $1.74 billion, down from $2.03 billion in 2024, driven by steel products segment margin compression, but projects increased earnings for Q1 2026 across all segments.

ZipRecruiter reported a net loss of $33.0 million in 2025 on reduced revenue, as macroeconomic conditions continued to impact hiring demand.

A10 Networks reported an 11% revenue increase to $290.6 million in 2025, driven by product demand, but net income declined 16% to $42.1 million.

Agilon Health reported a significant increase in net losses and a decline in Medicare Advantage and ACO beneficiaries for the fiscal year ended December 31, 2025, alongside NYSE delisting concerns.

Expeditors International of Washington, Inc. reported a 4% revenue increase in 2025, driven by strong airfreight and customs brokerage demand, despite an 11% decline in ocean freight revenues.

Hasbro reported a net loss of $322.4 million for fiscal year 2025, primarily due to a significant non-cash goodwill impairment charge of $1.02 billion in its Consumer Products segment.

Schrodinger, Inc. reported a 23% increase in total revenue to $255.9 million and significantly reduced its net loss to $103.3 million in 2025, driven by robust software sales and drug discovery collaborations, despite discontinuing a key clinical program.

Arcus Biosciences reports increased net losses in 2025, discontinues a Phase 3 trial, but strengthens its financial position with new equity and debt financing.

IonQ, a quantum platform company, reported a significant increase in net losses to $510.4 million in 2025, driven by aggressive R&D and strategic acquisitions, while revenue more than doubled to $130.0 million.

Revolution Medicines reports significant clinical advancements for its RAS(ON) inhibitor pipeline, including multiple FDA Breakthrough Therapy Designations, alongside increased R&D expenses and a net loss of $1.13 billion for 2025.

Edwards Lifesciences reported a significant increase in net sales for 2025, driven by strong performance in its TAVR and TMTT product groups, despite a decrease in net income due to higher operational and litigation expenses.

QuantumScape's 2025 10-K details continued solid-state battery development, key partnerships, and significant financial losses as it targets commercialization.

Net Lease Office Properties reports increased FFO and AFFO, significant debt reduction, and substantial special cash distributions amidst ongoing asset disposition strategy.

CareDx, a precision medicine company, reported a 14% increase in total revenue to $379.8 million for fiscal year 2025, alongside a net loss of $21.4 million, while successfully remediating a material weakness in internal controls and settling a securities class action.

First Financial Bankshares, Inc. reported a 13.45% increase in net earnings for 2025, driven by robust net interest income and asset growth, despite a significant credit loss from fraudulent activity.

Carlsmed, Inc. achieved significant revenue growth and expanded its AI-enabled personalized spine surgery platform into cervical fusion, backed by strong clinical evidence and favorable reimbursement updates.

The Honest Company reported a 1.9% revenue decline and a wider net loss for 2025 as it exited DTC, apparel and Canada, while unveiling a $25 million share repurchase and pushing ahead with its Powering Honest Growth plan.

Pebblebrook Hotel Trust reports mixed 2025 results with urban market recovery, resilient leisure demand, and strategic capital actions amidst regional challenges and an impairment loss.

MYR Group Inc. reports a significant surge in 2025 net income and gross profit, driven by robust demand in its Transmission & Distribution and Commercial & Industrial segments.

Planet Fitness, Inc. announced robust financial and operational performance for fiscal year 2025, driven by increased membership, club expansion, and higher revenue across all segments.

Arcutis Biotherapeutics reports significant revenue growth for its ZORYVE product line in 2025, driven by expanded indications and commercial launches, despite ongoing net losses and a terminated promotion agreement.

First Business Financial Services, Inc. reported a significant increase in net income and total assets for the fiscal year ended December 31, 2025, driven by loan growth and diversified revenue streams.

Celldex Therapeutics' 2025 annual report details significant clinical advancements for Barzolvolimab and CDX-622, alongside executive compensation updates and financial performance.

Catalyst Pharmaceuticals reported significant revenue and net income growth in its 2025 annual report, primarily fueled by the successful commercialization of AGAMREE and continued FIRDAPSE sales, despite generic competition for FYCOMPA.

MercadoLibre, the leading online commerce and fintech ecosystem in Latin America, reported significant revenue and user growth in 2025, driven by its e-commerce and Mercado Pago platforms, despite a decline in operating margins.